As of May 27
| +0.04 / +0.56%|
The 4 analysts offering 12-month price forecasts for Syneron Medical Ltd have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 9.40. The median estimate represents a +59.28% increase from the last price of 7.22.
The current consensus among 4 polled investment analysts is to Buy stock in Syneron Medical Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.